Literature DB >> 15635622

Synthesis and structural characterization of bioactive peptide conjugates using thioether linkage approaches.

Gábor Mezö1, Marilena Manea, Annamária Jakab, Bence Kapuvári, Szilvia Bösze, Gitta Schlosser, Michael Przybylski, Ferenc Hudecz.   

Abstract

Applications of cysteine-insertion and thioether linkage approaches to the preparation of a number of bioactive peptide conjugates are reported. Peptides containing epitopes from (i) herpes simplex virus type 1 glycoprotein D, (ii) a specific N-terminal beta-amyloid epitope recognized by therapeutically active antibodies, and (iii) a GnRH-III peptide from sea lamprey with antitumour activity, were elongated with Cys residues and attached to a chloroacetylated tetratuftsin derivative carrier via a thioether linkage either directly, or by insertion of a spacer. The structures and molecular homogeneity of all the peptide conjugates were ascertained by HPLC, MALDI and electrospray mass spectrometry. The use of a spacer such as an oligoglycine or GFLG-tetrapeptide gave an increased yield in the conjugation reaction and enhanced reaction rates. In the formation of cysteinyl-thioether linkages, it was found that the position of flanking Cys residues markedly influenced the conjugation reaction and the formation of intermolecular epitope disulfide-dimers. C-terminal Cys residues gave thioether conjugates with significantly diminished epitope-dimerization, while Cys at the N-terminal caused rapid disulfide-dimerization, thereby preventing efficient conjugation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15635622     DOI: 10.1002/psc.583

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  1 in total

1.  A Convenient Synthetic Method to Improve Immunogenicity of Mycobacterium tuberculosis Related T-Cell Epitope Peptides.

Authors:  Kata Horváti; Bernadett Pályi; Judit Henczkó; Gyula Balka; Eleonóra Szabó; Viktor Farkas; Beáta Biri-Kovács; Bálint Szeder; Kinga Fodor
Journal:  Vaccines (Basel)       Date:  2019-08-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.